ADAP - Adaptimmune Therapeutics Plc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - ADAP (1621227)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
26 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-06-18
ADAPPiccina CintiaChief Commercial OfficerS - Sale$0.93-24,53138,293-39%-$22,814
M
2024-01-16
ADAPRawcliffe AdrianCEOS - Sale$0.70-39,38444,848-47%-$27,594
M
2024-01-16
ADAPNorry ElliotChief Medical OfficerS - Sale$0.69-20,56319,257-52%-$14,106
M
2024-01-16
ADAPLunger JohnChief Patient Supply OfficerS - Sale$0.70-22,79519,015-55%-$15,889
M
2024-01-16
ADAPBertrand William C JrCOOS - Sale$0.70-23,58920,201-54%-$16,423
M
2024-01-11
ADAPNorry ElliotChief Medical OfficerS - Sale$0.85-11,80811,841-50%-$10,015
M
2024-01-11
ADAPBertrand William C JrCOOS - Sale$0.85-9,2297,874-54%-$7,813
M
2024-01-11
ADAPRawcliffe AdrianCEOS - Sale$0.85-29,20226,388-53%-$24,734
M
2024-01-11
ADAPLunger JohnChief Patient Supply OfficerS - Sale$0.85-9,2297,874-54%-$7,813
2023-09-01
ADAPRawcliffe AdrianCEOS - Sale$0.78-2,4033,449-41%-$1,874
2023-08-01
ADAPLunger JohnChief Patient Supply OfficerS - Sale$0.91-3,0964,718-40%-$2,804
2023-07-10
ADAPMenzel Garry EDirS - Sale$0.91-47,70275,056-39%-$43,447
2023-06-27
ADAPRawcliffe AdrianCEOS - Sale$0.92-2,3333,519-40%-$2,146
2023-01-31
ADAPPiccina CintiaChief Commercial OfficerS - Sale$1.87-11,89019,535-38%-$22,230
2023-01-17
ADAPLunger JohnChief Patient Supply OfficerS - Sale$1.86-4,4407,264-38%-$8,250
2023-01-17
ADAPBertrand William C JrCOOS - Sale$1.86-4,4407,264-38%-$8,250
2023-01-17
ADAPNorry ElliotChief Medical OfficerS - Sale$1.86-2,1593,491-38%-$4,011
2023-01-17
ADAPRawcliffe AdrianCEOS - Sale$1.86-10,05713,351-43%-$18,686
M
2023-01-11
ADAPBertrand William C JrCOOS - Sale$1.72-8,8168,121-52%-$15,197
M
2023-01-11
ADAPLunger JohnChief Patient Supply OfficerS - Sale$1.72-8,8168,121-52%-$15,197
M
2023-01-11
ADAPNorry ElliotChief Medical OfficerS - Sale$1.72-11,29212,191-48%-$19,421
M
2023-01-11
ADAPRawcliffe AdrianCEOS - Sale$1.72-31,80524,882-56%-$54,791
2023-01-04
ADAPBertrand William C JrCOOS - Sale$1.69-3,5845,781-38%-$6,071
2023-01-04
ADAPLunger JohnChief Patient Supply OfficerS - Sale$1.69-1,1001,725-39%-$1,863
2023-01-04
ADAPNorry ElliotChief Medical OfficerS - Sale$1.69-8761,361-39%-$1,484
2023-01-04
ADAPRawcliffe AdrianCEOS - Sale$1.69-5,0736,631-43%-$8,594

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top